Utility of 18F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 5, 2012, Pages 723-726

  Rosevear, Henry M ^a   Williams, Hadyn ^b   Collins, Matthew ^b   Lightfoot, Andrew J ^a   Coleman, Teresa ^b   Brown, James A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

18F FDG PET CT; Lymph nodes; Penile cancers

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BODY MASS; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INGUINAL REGION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; OBESITY; PENILE SQUAMOUS CELL CARCINOMA; PENIS CARCINOMA; PRIORITY JOURNAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; LYMPH NODE; METHODOLOGY; PATHOLOGY; PENIS TUMOR; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; PENILE NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84866764935     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.09.015     Document Type: Article

References (18)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
2. Derakhshani P., Neubauer S., Braun M., et al. Results and 10-year follow-up in patients with squamous cell carcinoma of the penis. Urol Int 1999, 62:238-244.
3. Riveros M., Garcia R., Cabanas R. Lymphadenography of the dorsal lymphatics of the penis. Tech Res Cancer 1967, 20:2026-2031.
4. Ornellas A.A., Kinchin E.W., Nóbrega B.L., et al. Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. J Surg Oncol 2008, 97:487-495.
5. Hughes B., Leijte J., Shabbir M., et al. Noninvasive and minimally invasive staging of regional lymph nodes in penile cancer. World J Urol 2009, 27:197-203.
6. Leijte J.A., Kroon B.K., Valdés Olmos R.A., et al. Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. Eur Urol 2007, 52:170-177.
7. Hadway P., Smith Y., Corbishley C., et al. Evaluation of dynamic lymphoscintigraphy and sentinel lymph-node biopsy for detecting occult metastases in patients with penile squamous cell carcinoma. BJU Int 2007, 100:561-565.
8. Pizzocaro G., Algaba F., Horenblas S., et al. EAU penile cancer guidelines 2009. Eur Urol 2010, 57:1002-1012.
9. 18F-FDG PET/CT for staging of penile cancer. J Nucl Med 2005, 46:1460-1465.
10. Graafland N.M., Leijte J.A., Valdés Olmos R.A., et al. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma. Eur Urol 2009, 56:339-345.
11. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in staging clinically node-negative patients with penile carcinoma. BJU Int 2009, 104:640-644.
12. Catalona W.J. Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: Technique and preliminary results. J Urol 1988, 140:306-310.
13. 18F-fluorodeoxyglucose PET/CT: a prospective single-center study. Urol Oncol 2012, 30:55-59.
14. Poulsen MH, Bouchelouche K, Gerke O, et al. 18F-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study. BJU Int, in press.
15. Drieskens O., Oyen R., Van Poppel H., et al. FDG-PET for preoperative staging of bladder cancer. Eur J Nucl Med Mol Imaging 2005, 32:1412-1417.
16. Kitajima K., Murakami K., Yamasaki E., et al. Accuracy of 18F-FDG PET/CT in detecting pelvic and para-aortic lymph node metastasis in patients with endometrial cancer. AJR Am J Roentgenol 2008, 190:1652-1658.
17. Lyford-Pike S., Ha P.K., Jacene H.A., et al. Limitations of PET/CT in determining need for neck dissection after primary chemoradiation for advanced head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2009, 71:251-256.
18. Fischer B.M., Olsen M.W., Ley C.D., et al. How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study. Eur J Nucl Med Mol Imaging 2006, 33:697-702.